Molecular characteristics of anaplastic astrocytomas and isolation of molecular subgroups of their IDH1 mutant forms using in silico analysis-Reference-Cited by-同舟云学术

Molecular characteristics of anaplastic astrocytomas and isolation of molecular subgroups of their IDH1 mutant forms using in silico analysis

Published:2020-10-07 Issue:3 Volume:19 Page:177-187
ISSN:1819-3684
Container-title:Bulletin of Siberian Medicine
language:
Short-container-title:Bûll. sib. med.

Author:

Nikitin P. V.¹^ORCID,Belyaev A. Yu.¹^ORCID,Ryzhov M. V.¹^ORCID

Affiliation:

1. Burdenko Neurosurgical Institute

Publisher

Siberian State Medical University

Subject

Molecular Medicine

Reference51 articles.

1. Louis D.N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W.K., Ohgaki H., Wiestler O.D., Kleihues P., Ellison D.W. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131 (6): 803–820. DOI: 10.1007/s00401-016-1545-1.

2. Ostrom Q.T., Gittleman H., Liao P., Vecchione-Koval T., Wolinsky Y., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary brain and other central nervous system tumors iagnosed in the United States in 2010–2014. Neuro Oncol. 2017; 19 (1-5): v1–88. DOI: 10.1093/neuonc/nox158.

3. Kobyakov G.L., Bekyashev A.Kh., Golanov A.V., Konova- lov A.N., Naskhletashvili D.R., Potapov A.A., Rzayev D.A., Ryzhova M.V., Smolin A .V., Trunin Yu.Yu., Ulitin A.Yu. Practical recommendations for the drug treatment of primary tumors of the central nervous system. Malignant Tumors. 2017; 7(3):77–92 (in Russ.).

4. Geisbrecht B.V., Gould S.J. The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase. J. Biol. Chem. 1999; 274 (43): 30527–30533.

5. Hartmann C., Hentschel B., Simon M., Westphal M., Schackert G., Tonn J.C., Loeffler M., Reifenberger G., Pietsch T., von Deimling A., Weller M.; German Glioma Network. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin. Cancer Res. 2013; 19 (18): 5146–5157. DOI: 10.1158/1078-0432.CCR-13-0017.